Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2023 Aug 16.

Published in final edited form as: Vaccine. 2021 May 4;39(23):3179–3188. doi: 10.1016/j.vaccine.2021.04.031

Figure 3. — Proportion and 95% Clopper Pearson Confidence Interval of S. aureus Positive Participants By Treatment Group and Study Visit Number -- Baseline S. aureus Nasal (a), Oral (b), and Nasal/Oral (c) Colonization Negative Subjects. The number of participants included in each analysis timepoint is included in the table.

Figure 3. — Proportion and 95% Clopper Pearson Confidence Interval of S. aureus Positive Participants By Treatment Group and Study Visit Number -- Baseline S. aureus Nasal (a), Oral (b), and Nasal/Oral (c) Colonization Negative Subjects. The number of participants included in each analysis timepoint is included in the table.